Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Management of Type 1 Diabetes with Advanced Technology
by
Singh Charan, Gopal
in
Automation
/ Diabetes
/ Glucagon
/ Glucose monitoring
/ Hypoglycemia
/ Infusion pumps
/ Insulin
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Management of Type 1 Diabetes with Advanced Technology
by
Singh Charan, Gopal
in
Automation
/ Diabetes
/ Glucagon
/ Glucose monitoring
/ Hypoglycemia
/ Infusion pumps
/ Insulin
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Management of Type 1 Diabetes with Advanced Technology
2024
Request Book From Autostore
and Choose the Collection Method
Overview
[LANGUAGE= \"English\"] The understanding and treatment of type 1 diabetes (T1D) is advancing with technological advances. The discovery of insulin in 1921 revolutionized diabetes treatment and paved the way for the development of insulin pumps (IP) continuous glucose monitors (CGMs) and artificial pancreas (AP) systems, which have significantly improved diabetes management. IP provides continuous insulin delivery, offering benefits, such as adaptability, precise dosing, and improved glycemic control. The CGMs enable real-time glucose monitoring, leading to enhanced glycemic management and reduced hypoglycemia risk. The AP systems combine CGM and IP technologies to automate insulin delivery, resulting in improved outcomes and potential dual hormone systems using insulin and glucagon. Despite the potential of these technologies, challenges exist in utilizing them in India, including cost, insurance coverage, availability, awareness, healthcare infrastructure, trained professionals, cultural barriers, and data management issues. However, ongoing research and advanced research utilizing cutting-edge technologies offer hope for new therapies and ultimately a cure for T1D.
Publisher
Kare Publishing
Subject
This website uses cookies to ensure you get the best experience on our website.